BioSpace News Archive

GN Store Nord: Transactions in Relation to Share Buyback Program – Dec. 27, 2017

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

December 27, 2017
·
2 min read
FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Cannabidiol (CBD) Oral Solution as Investigational Treatment for Prader-Willi Syndrome

Prader-Willi syndrome is the most common known genetic cause of life-threatening obesity in children.

December 27, 2017
·
3 min read
Drug Development

VBL Therapeutics Announces First Patient in Pivotal Phase III Study of VB-111 in Platinum Resistant Ovarian Cancer in Collaboration With the GOG Foundation, Inc.

The OVAL study will be conducted in collaboration with the Gynecologic Oncology Group (GOG) Foundation.

December 27, 2017
·
7 min read
Drug Development

Diffusion Pharmaceuticals Begins Phase III Clinical Trial With TSC in Glioblastoma Multiforme

The trial will screen 300 patients and enroll 264 in an effort to ensure that results from 236 patients will be available for analysis.

December 27, 2017
·
10 min read
Biotech Bay

Catalyst Biosciences Announces Closing of Public Offering of Common Stock

JonesTrading Institutional Services LLC and Ladenburg Thalmann & Co. Inc. are acting as Joint Book-running Managers and LifeSci Capital LLC is acting as a Co-Manager for the proposed offering.

December 27, 2017
·
3 min read
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program - Dec. 27, 2017

The purpose of the grant of warrants is to reflect the Company’s objective to incentivize long-term shareholder value creation.

December 27, 2017
·
2 min read
Business

MedMira Reports First Quarter Results

In Q1 FY2018, the Company recorded revenue of $143,042 compared to $212,245 in Q1 FY2017.

December 27, 2017
·
3 min read
BioCapital

India Globalization Capital to use Blockchain to Address Issues Specific to the Medical Cannabis Industry

According to a recent study that was published in JAMA and detailed on www.pennmedicine.org, nearly 70% of all cannabidiol products sold online are either over or under labeled.

December 27, 2017
·
2 min read